Kevin OLaughlin
Overview
Explore the profile of Kevin OLaughlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OLaughlin K, Huits R, Libman M, Kozarsky P, Hamer D
Ann Intern Med
. 2024 Nov;
178(1):116-118.
PMID: 39556840
No abstract available.
2.
Petras J, Elrod M, Ty M, Dawson P, OLaughlin K, Gee J, et al.
N Engl J Med
. 2023 Dec;
389(25):2355-2362.
PMID: 38118023
Melioidosis, caused by , is a rare but potentially fatal bacterial disease endemic to tropical and subtropical regions worldwide. It is typically acquired through contact with contaminated soil or fresh...
3.
Atherstone C, Guagliardo S, Hawksworth A, OLaughlin K, Wong K, Sloan M, et al.
Emerg Infect Dis
. 2023 Jul;
29(9):1757-1764.
PMID: 37494699
The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case...
4.
Haston J, OLaughlin K, Matteson K, Roy S, Qvarnstrom Y, Ali I, et al.
Open Forum Infect Dis
. 2023 Jan;
10(1):ofac682.
PMID: 36655187
Background: is a free-living ameba that can cause severe disease affecting the central nervous system, skin, sinuses, and other organs, particularly in immunocompromised individuals. These rare but severe infections are...
5.
Ohlsen E, Hawksworth A, Wong K, Guagliardo S, Fuller J, Sloan M, et al.
Emerg Infect Dis
. 2022 Dec;
28(13):S85-S92.
PMID: 36502409
Viral genomic surveillance has been a critical source of information during the COVID-19 pandemic, but publicly available data can be sparse, concentrated in wealthy countries, and often made public weeks...
6.
Miller M, Cash-Goldwasser S, Marx G, Schrodt C, Kimball A, Padgett K, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Nov;
71(44):1412-1417.
PMID: 36327164
As of October 21, 2022, a total of 27,884 monkeypox cases (confirmed and probable) have been reported in the United States. Gay, bisexual, and other men who have sex with...
7.
Rodriguez-Nava G, Kadlecik P, Filardo T, Ain D, Cooper J, McCormick D, et al.
Emerg Infect Dis
. 2022 Sep;
28(12):2508-2512.
PMID: 36179413
We report 2 immunocompetent and otherwise healthy adults in the United States who had monkeypox and required hospitalization for viral myocarditis. Both patients were unvaccinated against orthopoxviruses. They had shortness...
8.
Pastula D, Copeland M, Hannan M, Rapaka S, Kitani T, Kleiner E, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Sep;
71(38):1212-1215.
PMID: 36136957
Monkeypox virus (MPXV) is an orthopoxvirus in the Poxviridae family. The current multinational monkeypox outbreak has now spread to 96 countries that have not historically reported monkeypox, with most cases...
9.
OLaughlin K, Tobolowsky F, Elmor R, Overton R, OConnor S, Damon I, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Sep;
71(37):1190-1195.
PMID: 36107794
Currently, no Food and Drug Administration (FDA)-approved treatments for human monkeypox are available. Tecovirimat (Tpoxx), however, is an antiviral drug that has demonstrated efficacy in animal studies and is FDA-approved...
10.
Minhaj F, Petras J, Brown J, Mangla A, Russo K, Willut C, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Sep;
71(36):1155-1158.
PMID: 36074752
Since May 2022, approximately 20,000 cases of monkeypox have been identified in the United States, part of a global outbreak occurring in approximately 90 countries and currently affecting primarily gay,...